Satellos Bioscience's total assets for Q2 2025 were C$41.12M, a decrease of -7.33% from the previous quarter. MSCLF total liabilities were C$2.77M for the fiscal quarter, a 2.63% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.